(Q36746621)

English

Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

attention deficit hyperactivity disorder

1 reference

based on heuristic

inferred from title

author name string

Himanshu P Upadhyaya

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Primary Care Companion to the Journal of Clinical Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

211-221

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

ADHD: new pharmacological treatments on the horizon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Innovations and recent trends in the treatment of ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Abuse of prescription drugs and the risk of addiction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Attention-deficit/hyperactivity disorder and early-onset substance use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Sources of prescription drugs for illicit use

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

The epidemiology of dual diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Diagnosis and treatment of behavioral health disorders in pediatric practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Genetics of adult attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Hidden morbidity in pediatric primary care.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Substance use problems and associated psychiatric symptoms among adolescents in primary care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Validity of the CRAFFT substance abuse screening test among adolescent clinic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Trends in the prescribing of psychotropic medications to preschoolers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

29 September 2017

The effect of bupropion sustained-release on cigarette craving after smoking cessation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

28 June 2018

Psychopathology in preadolescent children at high risk for substance abuse: a review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

28 June 2018

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Attention deficit hyperactivity disorder and substance use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Testing the dual pathway hypothesis to substance use in adolescence and young adulthood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

History and current perspectives on the use of drug formulations to decrease the abuse of prescription drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Practice parameter for the assessment and treatment of children and adolescents with substance use disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Is there a link between adolescent cigarette smoking and pharmacotherapy for ADHD?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Does stimulant treatment lead to substance use disorders?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Genetic and environmental influences on adolescent substance use and abuse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Development of nicotinic drug therapy for cognitive disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Approaches to recognition and management of childhood psychiatric disorders in pediatric primary care.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Reliability and validity of the SKAMP rating scale in a laboratory school setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

5 September 2018

Psychiatric and psychosocial predictors of substance use disorders among adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

4 December 2018

Psychostimulant Treatment and Risk for Substance Abuse Among Young Adults with a History of Attention-Deficit/Hyperactivity Disorder: APopulation-Based, Birth Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446489

4 December 2018

A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. Findings from a high-risk sample of siblings

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability of the Problem Oriented Screening Instrument for Teenagers (POSIT) in adolescent medical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do patients with ADHD have a harder time quitting cigarettes?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Norms and sensitivity of the adolescent version of the drug use screening inventory

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk identification, risk assessment, and risk management of abusable drug formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further validation of new scales measuring adolescent alcohol and other drug abuse

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Research design strategies to evaluate the impact of formulations on abuse liability

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18615170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4088/PCC.V10N0306

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36746621&oldid=2126811069"